Intravenous Immunoglobulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Thursday, December 6, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Dec. 5, 2018 /PRNewswire/ -- Intravenous Immunoglobulin Market (Indication - Chronic Inflammatory Demyelinating Polyneuropathy, Primary Humoral Immunodeficiency, Idiopathic Thrombocytopenic Purpura, Guillain-Barre Syndrome, Myasthenia Gravis, Multifocal Motor Neuropathy, Kawasaki Disease, Hypogammaglobulinemia, Chronic Lymphocytic Leukemia; End user - Hospitals, Clinics, Home Care) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Download the full report: Global Intravenous Immunoglobulin Market: Scope and MethodologyThis report analyzes the current and future prospects of the global intravenous immunoglobulin market.It
comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments.The report is a combination of primary and secondary research.Primary research formed the bulk of the research efforts along with information collected from telephonic interviews and interactions via e-mails.Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases.The report provides market size in terms of US$ Mn for each segment for the period from 2016 to 2026, considering the macro and micro environmental factors.Growth rates for each segment within the global intravenous immunoglobulin market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.A detailed qualitative analysis of factors responsible for driving and restraining market and future opportunities has been provided in the overview section.This section of the report also provides insights into the key trends of the intravenous immunoglobulin market such as shift from intravenous to subcutaneous infusion of immunoglobulin.The key indicators influencing the global intravenous immunoglobulin market taken into consideration include prevalence of immunological disorders, global blood and plasma yield, and geriatric population.The report also includes market attractiveness analysis of the major segments that provides a thorough analysis of the overall competitive scenario in the global intravenous immunoglobulin market.The report also highlights key events of the global intravenous immunoglobulin industry. A value chain analysis along with list of major players, hospitals, and distributors is also included in the report.Market revenue in terms of US$ Mn for the period between 2016 and 2026 along with the compound annual growth rate (CAGR %) from 2018 to 2026 are provided for all the segments, considering 2017 as the base year.The year-on-year growth of the global intravenous immunoglobulin market for each segment is also reflected.Additionally, market related factors such as increase in preference for product innovation and rise in the number of acute and chronic patients in various regions and historical year-on-year growth have been taken into consideration while estimating the market size.Global Intravenous Immunoglobulin Market: SegmentationBased on indication, the global intravenous immunoglobulin market has been segmented into chronic inflammatory demyelinating polyneuropathy (CIDP), primary humoral immunodeficiency, idiopathic thrombocytopenic purpura (ITP), Guillain-Barre syndrome, myasthenia gravis, multifocal motor neuropathy (MMN), Kawasaki disease, hypogammaglobulinemia, chronic lymphocytic leukemia, and others.In terms of end-user, the global market has been segmented into hospitals, clinics, and home care.The hospitals segment is projected to dominate the market during the forecast period. However, the home care segment is expected to expand at the highest CAGR during the forecast period.Geographically, the global intravenous immunoglobulin market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.Additionally, the regions have been divided into major countries/sub-regions.These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Japan, India, Australia, Brazil, and Mexico.Global Intravenous immunoglobulin Market: Competitive LandscapeThe report also profiles major players in the global intravenous immunoglobulin market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments.A thorough market share analysis of major companies operating in the global intravenous immunoglobulin market is provided in the report.The report also includes a competition matrix that provides insights into recent developments and activities undertaken by the major players. Key companies profiled in the report include Shire plc, ADMA Biologics, Inc., China Biologic Products, Inc., CSL Behring LLC, Grifols S.A., Kedrion S.p.A., LFB Biomedicaments S.A., Octapharma AG, and Sanquin Plasma Products B.V.The global intravenous immunoglobulin market has been segmented as follows:Global Intravenous immunoglobulin Market, by IndicationChronic Inflammatory Demyelinating Polyneuropathy (CIDP)Primary Humoral ImmunodeficiencyIdiopathic Thrombocytopenic Purpura (ITP)Guillain-Barre SyndromeMyasthenia GravisMultifocal Motor Neuropathy (MMN)Kawasaki DiseaseHypogammaglobulinemiaChronic Lymphocytic LeukemiaOthersGlobal Intravenous Immunoglobulin Market, by End-userHospitalsClinicsHome CareGlobal Intravenous Immunoglobulin Market, by RegionNorth AmericaU.S.CanadaEuropeGermanyU.K.FranceSpainItalyRest of EuropeAsia PacificAustralia & New ZealandJapanChinaIndiaRest of Asia PacificLatin AmericaBrazilMexicoRest of Latin AmericaMiddle East & AfricaGCC CountriesSouth AfricaRest of Middle East & AfricaDownload the full report: About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Email: Tel: +1 (718) 213 4904 Website:

Cision View original content:

SOURCE ReportBuyer

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store